Armistice Capital, LLC 13D and 13G filings for Autolus Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 9:51 pm Purchase | 2025-12-31 | 13G | Autolus Therapeutics plc AUTL | Armistice Capital, LLC | 17,500,000 6.580% | 1,900,000 (+12.18%) | Filing |
| 2025-11-14 6:38 pm Purchase | 2025-09-30 | 13G | Autolus Therapeutics plc AUTL | Armistice Capital, LLC | 15,600,000 5.860% | 11,750,000 (+305.19%) | Filing |
| 2025-08-14 8:46 pm Purchase | 2025-06-30 | 13G | Autolus Therapeutics plc AUTL | Armistice Capital, LLC | 1,178,389 4.990% | 1,178,389 (New Position) | Filing |
| 2024-02-14 2:41 pm Sale | 2023-12-31 | 13G | Autolus Therapeutics plc AUTL | Armistice Capital, LLC | 3,850,000 2.210% | -6,374,000 (-62.34%) | Filing |
| 2023-02-14 12:02 pm Purchase | 2022-12-31 | 13G | Autolus Therapeutics plc AUTL | Armistice Capital, LLC | 10,224,000 5.910% | 10,224,000 (New Position) | Filing |